abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
36303: Infliximab Level For IBD Print View
Infliximab Level, IBD ELISA    mcg/mL 
Interpretation      
Comment      

PRIMARY
1 Serum Red Top 1 (0.5) mL   Frozen - 14 Day(s)/Refrigerated - 7 Day(s)/Room Temperature - 48 Hour(s)  
ALTERNATE

When treatment of inflammatory bowel disease with infliximab fails, a physician may need to consider treatment options, such as adjusting dose or dosing intervals, switching to a different TNF blocker, or switching to a different drug agent, i.e. a non-TNF blocker. This assay specifically measures serum infliximab levels. The American Gastroenterological Association recommends optimal infliximab trough concentration of 5 mcg/mL or greater in patients with active IBD. Data from separate clinical studies suggest an optimal infliximab trough concentration of greater than 3.8 or 6-10 mcg/mL.

The blood should be drawn just before the next infusion of
infliximab to measure the trough drug level.
Setup Schedule
Tuesday

Reported (Analytical Time)
2 days

CPT Code
80299

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
**This test is not available for New York patient testing**
Reject Criteria: Serum Separator Tube; gross hemolysis
Transport Temperature: Refrigerated
Specimen Stability:
Frozen (-20 degrees Celsius): 14 days
Frozen (-70 degrees Celsius): 60 days
Methodology: Enzyme Linked Immunosorbent Assay






1996 - 2018 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database